Leadership Overview
Bosnalijek has 4 executives leading key functions including strategy, operational management, financial oversight, and global market expansion.
Focused on advancing pharmaceutical innovation, Bosnalijek maintains a steadfast commitment to improving patient outcomes through high-quality medicine manufacturing. This organization prioritizes social responsibility while delivering essential healthcare solutions across diverse international markets.
Focused on advancing pharmaceutical innovation, Bosnalijek maintains a steadfast commitment to improving patient outcomes through high-quality medicine manufacturing. This organization prioritizes social responsibility while delivering essential healthcare solutions across diverse international markets.
Leadership Roles at Bosnalijek
Edin Arslanagic - Chief Executive Officer
Edin Arslanagic, the Chief Executive Officer at Bosnalijek, directs the overarching strategic vision for the largest industrial manufacturer of medicines in Bosnia and Herzegovina. By aligning corporate objectives with global pharmaceutical standards, the Chief Executive Officer ensures consistent growth and operational excellence. Edin Arslanagic manages high-level interactions with the Board to secure long-term stability and market leadership. This executive role involves overseeing the development of preventive actions and cures, ensuring the company meets the evolving needs of patients. Through rigorous quality control and innovation, the Chief Executive Officer drives the organization toward international expansion. By fostering a culture of excellence, the Chief Executive Officer maintains the company's reputation for reliability. Arslanagic consistently evaluates market trends to refine the corporate mission, ultimately securing the company's position as a premier provider of healthcare solutions while upholding the highest standards of social responsibility.

Lana Mujanović - Deputy Chief Executive Officer
Lana Mujanović, the Deputy Chief Executive Officer at Bosnalijek, executes daily operational workflows to support the company's mission of improving patient quality of life. The Deputy Chief Executive Officer coordinates cross-departmental initiatives to ensure seamless production cycles for pharmaceutical products. Lana Mujanović monitors internal efficiency metrics, identifying opportunities for process optimization within the manufacturing facilities. This leadership role requires close collaboration with the Chief Executive Officer to implement strategic directives across all business units. By managing resource allocation and operational logistics, the Deputy Chief Executive Officer sustains the company's competitive edge in the regional market. Mujanović oversees the integration of new technologies to enhance manufacturing capabilities, ensuring compliance with international safety standards. Through proactive management of internal operations, the Deputy Chief Executive Officer supports the company's commitment to delivering high-quality medicines, thereby strengthening the overall market impact and operational resilience of the organization.
Mirza Kasum - Chief Financial Officer
Mirza Kasum, the Chief Financial Officer at Bosnalijek, manages the fiscal health and capital allocation strategies for the organization. The Chief Financial Officer directs financial planning, budgeting, and reporting processes to ensure transparency for shareholders and stakeholders. Mirza Kasum evaluates investment opportunities in pharmaceutical research and development to drive long-term value creation. This leadership role involves maintaining robust financial controls and risk management frameworks to support the company's international growth objectives. By analyzing market data and economic indicators, the Chief Financial Officer provides critical insights that inform strategic decision-making at the executive level. Kasum oversees the financial stability of the company, ensuring sufficient liquidity for ongoing operations and infrastructure improvements. Through disciplined fiscal management, the Chief Financial Officer secures the resources necessary for the company to continue its mission of providing essential medicines, ultimately contributing to the sustained financial success and market stability of the firm.
Admir Kešo - Chief Marketing & Sales Officer
Admir Kešo, the Chief Marketing & Sales Officer at Bosnalijek, architects the commercial strategy to expand the reach of pharmaceutical products across diverse geographic regions. The Chief Marketing & Sales Officer drives brand awareness and market penetration by aligning product offerings with the specific needs of healthcare providers and patients. Admir Kešo manages relationships with key distributors and partners to ensure the effective delivery of medicines. This leadership role involves analyzing competitive landscapes to refine sales tactics and promotional campaigns. By overseeing the commercial team, the Chief Marketing & Sales Officer ensures that the company's commitment to quality and innovation remains central to all customer interactions. Kešo monitors sales performance metrics to identify growth opportunities in emerging markets. Through strategic market positioning, the Chief Marketing & Sales Officer enhances the company's visibility and influence, ensuring that the organization effectively meets the expectations of its customers while achieving ambitious revenue targets.
Explore Leadership Teams in Manufacturing
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a global healthcare company delivering innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products.
Company Leadership SP
RB
NM
JH
PharmaLogic Holdings Corp. is a global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Through a network of radiopharmacies and manufacturing facilities across North America and Europe, it develops, manufactures, and distributes clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers.
Company Leadership
HP
GP
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities.
Company Leadership NL
SC
MP
KD
Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines.
Company Leadership
HA
AS
MB